Rebalix
Invesco · sheet of 5 September 2026
Invesco · sheet of 5 September 2026ETF sheet · official issuer and register data
Invesco MSCI USA Universal Screened UCITS ETF Dist
ESUS · IE000A8N67F3 · class Dist · USD · domicile Ireland
Equity · United StatesSFDR art. 8
Index tracked: MSCI USA Universal Select Business Screens Index
- TER
- 0.09%+ trans. 0.00%
- Fund size
- 2.7 bn EUR
- Tracking difference
- +0.16%3-year avg
- 🇮🇹 tax rate
- 26.00%white list 0.00%
- Replication
- Physical
- Income
- Distributingquarterly
Launch 9 Aug 2021 · costs from the KID as of 14 Aug 2026 · 471 securities held
The fund’s objective — in the issuer’s words
From the Key Information Document (KID) · 14 Aug 2026
Investment objective: The investment objective of the Fund is to achieve the net total return performance of the MSCI USA Universal Select Business Screens Index (the "Index"), less fees, expenses and transaction costs. Dividend Policy: This Share Class declares and distributes a dividend on a quarterly basis. Investment approach: The Fund is a passively managed ETF. To achieve the investment objective, the Fund will, as far as possible and practicable, hold all the securities in the Index in their respective weightings. The Fund may use derivative…
Performance since series start (in euro) — base 100
9 Aug 2021 → 1 Sept 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
Returns in euro
| 1 year | +20.0% |
| 3 years | +61.0% |
| 5 years | +73.6% |
| 10 years | series too young |
| Since series start | +76.3% |
Risk · 1 / 3 / 5 years
| Volatility (ann.) | 13.70% | 15.34% | 17.59% |
| Max drawdown | −9.98% | −19.18% | −28.59% |
| Sharpe | 1.25 | 1.03 | 0.50 |
| Sortino | 1.83 | 1.52 | 0.72 |
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · ESUS · IE000A8N67F31
RebalixESUS · IE000A8N67F3 · sheet of 5 September 2026
Tracking difference — year by year
Fund minus index, complete calendar years · from issuer-declared series
| Year | Fund | Index | TD |
|---|---|---|---|
| 2025 | +15.49% | +15.37% | +0.12% |
| 2024 | +24.08% | +23.96% | +0.12% |
| 2023 | +27.44% | +27.20% | +0.23% |
| 2022 | −21.61% | −21.72% | +0.11% |
Distributions · per share, in USD
Frequency: quarterly · last 12 months: 0.9149 USD (0.83% of NAV) · last ex-date 10 Sept 2026
| Year | Payments | Total (USD) | Dividend yield |
|---|---|---|---|
| 2026 | 3 | 0.7158 | — |
| 2025 | 4 | 0.8798 | +1.04% |
| 2024 | 4 | 0.8365 | +1.21% |
| 2023 | 4 | 0.8155 | +1.48% |
| 2022 | 4 | 0.7576 | +1.07% |
Dividend yield: the year’s distributions over the share value (NAV) at the start of the year.
Holdings
Portfolio as declared by the issuer · 1 Sept 2026 · 471 securities · top-10 weight = 32.5%
| Top holdings | Weight |
|---|---|
| 5.8% | |
| 5.2% | |
| 4.7% | |
| 4.3% | |
| 3.2% | |
| 2.3% | |
| 2.0% | |
| 1.8% | |
| 1.6% | |
| 1.4% |
Listing venues
ESMA register (FIRDS) and official exchange lists
No EU listing in the ESMA register.
Official documents
Clickable links in the PDF
The live sheet, always up to date
rebalix.com/en/etf/IE000A8N67F3
Series, distributions, holdings and documents refresh daily.
rebalix.com/en/etf/IE000A8N67F3
Series, distributions, holdings and documents refresh daily.
Sheet produced on 5 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.
Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.
Rebalix · ESUS · IE000A8N67F32